Baraclude: Clinical Trials

20 trials of Baraclude, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 unknown, 7 completed, 1 recruiting, 1 terminated. 20 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 420Unknown 10, Completed 7, Recruiting 1, Terminated 1, Withdrawn 1

Follow Baraclude: new trials by email Literature Review of Baraclude trials Research Report on Baraclude

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
Tenofovir alafenamide, Entecavir - Hepatitis B, Viral Hepatitis
Phase 4RecruitingTaichung Veterans General Hospital1402019-08-192026-05-14
Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis(HBV-GN)
Tacrolimus &entecavir, placebo & entecavir - Hepatitis B Virus Associated Nephrotic Syndrome
Phase 4UnknownGuangdong Provincial People's Hospital1122017-02-012017-02-24
Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection
Entecavir or Tenofovir, Peginterferon Alfa-2B - Chronic Hepatitis b
Phase 4UnknownThird Affiliated Hospital, Sun Yat-Sen University1002016-01-012016-11-25
Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude
Cavir, Baraclude - Chronic Hepatitis B
Phase 4UnknownHanmi Pharmaceutical Company Limited1342015-01-012015-08-14
Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients
Entecavir - Rheumatoid Arthritis, Hepatitis B Reactivation
Phase 4UnknownTaipei Veterans General Hospital, Taiwan1152013-09-102019-03-13
Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma
Entecavir prophylaxis, Observation arm - Hepatitis B
Phase 4UnknownPeking University1902013-01-012017-01-10
Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy
Entecavir prophylaxis - Hepatitis B
Phase 4UnknownPeking University802013-01-012017-01-10
Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B
Tenofovir, Entecavir - Chronic Viral Hepatitis B Without Delta-agent
Phase 4CompletedAsan Medical Center882012-09-282018-05-09
Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B
Tenofovir, Entecavir - Chronic Viral Hepatitis B Without Delta-agent
Phase 4CompletedAsan Medical Center1022012-09-252018-02-20
Antiviral Efficacy of Switching to ETV Plus TDF
Group A (Zeffix, Sebivo, Hepsera), Group B (Baraclude, Viread) - Chronic Hepatitis B
Phase 4UnknownYonsei University1042012-08-012014-01-31
Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir
Telbivudine, Tenofovir, Entecavir - Chronic Hepatitis B
Phase 4UnknownPusan National University Yangsan Hospital1042012-04-012012-05-02
Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis B
Peg-IFNα-2a, Entecavir - Chronic Hepatitis B
Phase 4UnknownBeijing 302 Hospital1052011-07-012015-08-17
Entecavir Plus Adefovir in Lamivudine-Resistant Patients
Lamivudine, Entecavir, Adefovir - Hepatitis B, Chronic
Phase 4WithdrawnBristol-Myers Squibb2009-12-012015-09-01
Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B
pegylated interferon a-2a, Entecavir - Chronic Hepatitis B
Phase 4CompletedFoundation for Liver Research1842009-08-012014-03-28
A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients
Clevudine, Entecavir - Chronic Hepatitis B
Phase 4TerminatedBukwang Pharmaceutical752009-08-012014-12-18
Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B
Entecavir prophylaxis, Therapeutic entecavir - Non Hodgkin's Lymphoma, Hepatitis B
Phase 4CompletedTaipei Veterans General Hospital, Taiwan802009-04-012013-05-29
Suboptimal Responders to Adefovir Switching to Entecavir
Entecavir, Adefovir/Entecavir - Hepatitis B, Chronic
Phase 4CompletedBristol-Myers Squibb2282008-07-012013-02-11
Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis
Entecavir - Hepatitis B Virus, Decompensated Cirrhosis
Phase 4UnknownShanghai Changzheng Hospital2002008-01-012008-04-23
A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection
Entecavir, Lamivudine Placebo, Lamivudine - Chronic Hepatitis B
Phase 4CompletedBristol-Myers Squibb1222007-02-012014-11-26
Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection
Entecavir - Hepatitis B Infection
Phase 4CompletedBristol-Myers Squibb1312006-11-012012-04-16

Conditions studied

Hepatitis B, Chronic (10)  ·  Hepatitis B (7)  ·  Lymphoma (3)  ·  Arthritis, Rheumatoid (1)  ·  Fibrosis (1)  ·  Glomerulonephritis, Membranous (1)  ·  Lymphoma, Non-Hodgkin (1)

Sponsors

Bristol-Myers Squibb (4)  ·  Asan Medical Center (2)  ·  Peking University (2)  ·  Taipei Veterans General Hospital, Taiwan (2)  ·  Beijing 302 Hospital (1)  ·  Bukwang Pharmaceutical (1)  ·  Foundation for Liver Research (1)  ·  Guangdong Provincial People's Hospital (1)  ·  Hanmi Pharmaceutical Company Limited (1)  ·  Pusan National University Yangsan Hospital (1)  ·  Shanghai Changzheng Hospital (1)  ·  Taichung Veterans General Hospital (1)  ·  Third Affiliated Hospital, Sun Yat-Sen University (1)  ·  Yonsei University (1)

Countries

China (8)  ·  South Korea (6)  ·  Taiwan (3)  ·  Brazil (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Romania (1)  ·  South Africa (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Top investigators

Jun Zhu (2)  ·  Fu-Sheng Wang, Professor (1)  ·  Jian Shi, MD (1)  ·  Ki Tae Yoon, M.D. (1)  ·  Liang Peng, Doctor (1)  ·  Lifen Wang, PHD (1)  ·  Lixia Xu, PHD (1)  ·  Sang Hoon Ahn, MD, PhD (1)  ·  Teng-Yu Lee, MD, PhD (1)  ·  Wei Shi, PHD (1)  ·  Xinling Liang, PHD (1)  ·  Yi-Hsiang Huang, MD, Ph.D. (1)  ·  Yi-Hsiang Huang, MD, PhD (1)

Results publications

PMID 30876946, PMID 10613747, PMID 15470215, PMID 15565615, PMID 15985009, PMID 16164651, PMID 16525138, PMID 16879891, PMID 17377504, PMID 19052126, PMID 20220333, PMID 2023605, PMID 2142748, PMID 21677438, PMID 22371643, PMID 22668640, PMID 23150796, PMID 23449768, PMID 23689577, PMID 23732715, PMID 23775967, PMID 24189358, PMID 24375637, PMID 25348661, PMID 25476749, PMID 25596179, PMID 25800784, PMID 26389937, PMID 28404091, PMID 28404092, PMID 28427875, PMID 29405329, PMID 29696665, PMID 30689258, PMID 32460460, PMID 35599306, PMID 35672893, PMID 35941076, PMID 757978